An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The clinical development of an inhibitor of cellular proteasome function suggests that compounds targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies. NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome. Substrates of cullin-RING ligases have important roles in cellular processes associated with cancer cell growth and survival pathways. Here we describe MLN4924, a potent and selective inhibitor of NAE. MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumour cells by a new mechanism of action, the deregulation of S-phase DNA synthesis. MLN4924 suppressed the growth of human tumour xenografts in mice at compound exposures that were well tolerated. Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“orthogonally confirmed dose-dependent KAT2A degradation by western blot, and demonstrated that this degradation can be rescued by pre-treatment with a UBA3/NAE1 inhibitor, MLN4924 (37), a proteasome inhibitor, bortezomib (38), and a competing CRBN ligand, pomalidomide (7) (Fig. 1D).”
From Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues (2026) · cites this paper as [37]
In the citing paper
“we cotreated cells with a proteasome inhibitor (bortezomib) or a NEDD8-activating enzyme E1 inhibitor (MLN-4924 32 ) and found that both inhibitors prevented degradation of BTK (Figure 2D).”
From Bruton tyrosine kinase degradation as a therapeutic strategy for cancer (2019) · cites this paper as [32]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Self-citationKobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Function and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins
Kerscher, O., Felberbaum, R., & Hochstrasser, M. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093503 · Cited by 1,517
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Duda, D. M., Borg, L. A., Scott, D. C., Hunt, H. W., Hammel, M., & Schulman, B. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.022 · Cited by 767
Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R. C., & Conaway, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190332597 · Cited by 653
Velcade®: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy
Kane, R. C., Bross, P. F., Farrell, A. T., & Pazdur, R. (2003) · The Oncologist · doi:10.1634/theoncologist.8-6-508 · Cited by 628
Cited by
Items 201–300 of 1,005
Chen, H., Liu, J., Kaniskan, H. Ü., Wei, W., & Jin, J. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00901 · Cited by 118
MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival
Lee, C.-S., Lee, L. C., Yuan, T. L., Chakka, S., Fellmann, C., Lowe, S. W., Caplen, N. J., McCormick, F., & Luo, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817494116 · Cited by 126
Transcription factor Etv5 is essential for the maintenance of alveolar type II cells
Zhang, Z., Newton, K., Kummerfeld, S., Webster, J. D., Kirkpatrick, D. S., Phu, L., Eastham‐Anderson, J., Liu, J., Lee, W. P., Wu, J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621177114 · Cited by 128
Adams, C. M., Mitra, R., Xiao, Y., Michener, P., Palazzo, J., Chao, A., Gour, J., Cassel, J. A., Salvino, J. M., & Eischen, C. M. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1131 · Cited by 139
Isolation and analysis of rereplicated DNA by Rerep-Seq
Menzel, J., Tatman, P., & Black, J. C. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa197 · Cited by 126
Tao, Y., Remillard, D., Vinogradova, E. V., Yokoyama, M., Banchenko, S., Schwefel, D., Melillo, B. N., Schreiber, S. L., Zhang, X., & Cravatt, B. F. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c08964 · Cited by 133
Yang, K., Wu, H., Zhang, Z., Leisten, E. D., Nie, X., Liu, B., Wen, Z., Zhang, J., Cunningham, M. D., & Tang, W. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00046 · Cited by 124
Self-citationRegulation of Skp2 Expression and Activity and Its Role in Cancer Progression
Chan, C., Lee, S.-W., Wang, J., & Lin, H.-K. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.89 · Cited by 127
Chen, P., Hu, T., Liang, Y., Li, P., Chen, X., Zhang, J., Ma, Y., Hao, Q., Wang, J., Zhang, P., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2254 · Cited by 124
Self-citationPerlíková, P., & Hocek, M. (2017) · Medicinal Research Reviews · doi:10.1002/med.21465 · Cited by 124
C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions
Mohanan, V., Nakata, T., Desch, A. N., Lévesque, C., Boroughs, A. C., Guzman, G., Cao, Z., Creasey, E. A., Yao, J., Boucher, G., et al. (2018) · Science · doi:10.1126/science.aan0814 · Cited by 141
Monda, J. K., Scott, D. C., Miller, D. J., Lydeard, J., King, D., Harper, J. W., Bennett, E. J., & Schulman, B. A. (2013) · Structure · doi:10.1016/j.str.2012.10.013 · Cited by 120
Emerging therapies targeting the ubiquitin proteasome system in cancer
Weathington, N. M., & Mallampalli, R. K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71602 · Cited by 124
Saha, A., Lewis, S. M., Kleiger, G., Kuhlman, B. A., & Deshaies, R. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.016 · Cited by 129
Mayor-Ruiz, C., Jaeger, M. G., Bauer, S., Brand, M., Sin, C., Hanzl, A., Mueller, A. C., Menche, J., & Winter, G. E. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.013 · Cited by 119
Tan, M.-K. M., Lim, H.-J., Bennett, E. J., Shi, Y., & Harper, J. W. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.018 · Cited by 130
Emberley, E. D., Mosadeghi, R., & Deshaies, R. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.352484 · Cited by 116
The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
Moran-Crusio, K., King, B., Reavie, L. B., & Aifantis, I. (2010) · Oncogene · doi:10.1038/onc.2010.222 · Cited by 117
Nawrocki, S. T., Kelly, K. R., Smith, P. G., Espitia, C. M., Possemato, A. P., Beausoleil, S. A., Milhollen, M. A., Blakemore, S. J., Thomas, M., Berger, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3212 · Cited by 117
Self-citationMichelena, J., Lezaja, A., Teloni, F., Schmid, T., Imhof, R., & Altmeyer, M. (2018) · Nature Communications · doi:10.1038/s41467-018-05031-9 · Cited by 115
Identifying druggable disease-modifying gene products
Dixon, S. J., & Stockwell, B. R. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.08.003 · Cited by 129
PPARγ neddylation essential for adipogenesis is a potential target for treating obesity
Park, H.-S., Ju, U.-I., Park, J.-W., Song, J. Y., Shin, D. H., Lee, K.-H., Jeong, L. S., Yu, J., Lee, H. W., Cho, J., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.6 · Cited by 116
Self-citationBhatia, S., Pavlick, A. C., Boasberg, P. D., Thompson, J. A., Mulligan, G., Pickard, M. D., Faessel, H. M., Dezube, B. J., & Hamid, O. (2016) · Investigational New Drugs · doi:10.1007/s10637-016-0348-5 · Cited by 118
Hewings, D. S., Flygare, J. A., Bogyo, M. S., & Wertz, I. E. (2017) · FEBS Journal · doi:10.1111/febs.14039 · Cited by 127
Mackintosh, C., Ordóñez, J. L., García-Domínguez, D. J., Sevillano, V., Llombart‐Bosch, A., Szuhai, K., Scotlandi, K., Alberghini, M., Sciot, R., Sinnaeve, F., et al. (2011) · Oncogene · doi:10.1038/onc.2011.317 · Cited by 116
Zhou, W., Wei, W., & Sun, Y. (2013) · Cell Research · doi:10.1038/cr.2013.44 · Cited by 123
RIT1 oncoproteins escape LZTR1-mediated proteolysis
Castel, P., Cheng, A. S., Cuevas-Navarro, A., Everman, D. B., Papageorge, A. G., Simanshu, D. K., Tankka, A. T., Galeas, J., Urisman, A., & McCormick, F. P. (2019) · Science · doi:10.1126/science.aav1444 · Cited by 120
Jenster, L., Lange, K.-E., Normann, S., Hemdt, A. V., Wuerth, J. D., Schiffelers, L. D. J., Tesfamariam, Y. M., Gohr, F. N., Klein, L., Kaltheuner, I. H., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220837 · Cited by 119
Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy
Meng, Y., Qiu, L., Zeng, X., Hu, X., Zhang, Y., Wan, X., Mao, X., Wu, J., Xu, Y., Xiong, Q., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01253-y · Cited by 123
The Investigation of Nfκb Inhibitors to Block Cell Proliferation in OSCC Cells Lines
Cheng, Y., Wang, L., Zhang, S., Wei, J., Zeng, B., Liang, L., & Deng, Z. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673309489240816063313 · Cited by 125
Gastaldello, S., Hildebrand, S., Faridani, O. R., Callegari, S., Palmkvist, M., Guglielmo, C. D., & Masucci, M. G. (2010) · Nature Cell Biology · doi:10.1038/ncb2035 · Cited by 127
Emerging regulatory mechanisms in ubiquitin-dependent cell cycle control
Mocciaro, A., & Rapé, M. (2012) · Journal of Cell Science · doi:10.1242/jcs.091199 · Cited by 113
CUL-2LRR-1 and UBXN-3 drive replisome disassembly during DNA replication termination and mitosis
Sonneville, R., Moreno, S. P., Knebel, A., Johnson, C., Hastie, C. J., Gartner, A., Gambus, A., & Labib, K. (2017) · Nature Cell Biology · doi:10.1038/ncb3500 · Cited by 108
Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B
Hannah, J., & Zhou, P. (2015) · Gene · doi:10.1016/j.gene.2015.08.064 · Cited by 110
Enzymatic Logic of Ubiquitin Chain Assembly
Deol, K. K., Lorenz, S., & Strieter, E. R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00835 · Cited by 129
Sekeres, M. A., Watts, J. M., Radinoff, A., Sangerman, M. A., Cerrano, M., Font, P., Zeidner, J. F., Díez‐Campelo, M., Graux, C., Liesveld, J. L., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01125-4 · Cited by 115
The Fbw7 and BetaTRCP E3 ubiquitin ligases and their roles in tumorigenesis
Alan, W. L. (2012) · Frontiers in bioscience · doi:10.2741/4045 · Cited by 122
TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin‐RING ligase complexes
Kelsall, I. R., Duda, D. M., Olszewski, J. L., Hofmann, K., Knebel, A., Langevin, F., Wood, N. T., Wightman, M., Schulman, B. A., & Alpi, A. F. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.209 · Cited by 116
Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells
Lan, H., Tang, Z., Jin, H., & Sun, Y. (2016) · Scientific Reports · doi:10.1038/srep24218 · Cited by 112
E1 Enzymes as Therapeutic Targets in Cancer
Barghout, S. H., & Schimmer, A. D. (2020) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000053 · Cited by 118
A Fast Workflow for Identification and Quantification of Proteomes
Ding, C., Jiang, J., Wei, J., Liu, W., Zhang, W., Liu, M., Fu, T., Lu, T., Song, L., Ying, W., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.025023 · Cited by 111
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
McGrail, D. J., Garnett, J., Yin, J., Dai, H., Shih, D. J. H., Lam, T., Li, Y., Sun, C., Li, Y., Schmandt, R. E., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.01.011 · Cited by 119
Milhollen, M. A., Thomas, M. P., Narayanan, U., Traore, T., Riceberg, J., Amidon, B., Bence, N., Bolen, J. B., Brownell, J. E., Dick, L. R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.009 · Cited by 109
Self-citationCand1-Mediated Adaptive Exchange Mechanism Enables Variation in F-Box Protein Expression
Liu, X., Reitsma, J. M., Mamrosh, J. L., Zhang, Y., Straube, R., & Deshaies, R. J. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.038 · Cited by 108
Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities
Landré, V., Rotblat, B., Melino, S., Bernassola, F., & Melino, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2431 · Cited by 113
Changes in the ratio of free NEDD8 to ubiquitin triggers NEDDylation by ubiquitin enzymes
Hjerpe, R., Thomas, Y., Chen, J., Zemla, A., Curran, S., Shpiro, N., Dick, L. R., & Kurz, T. (2011) · Biochemical Journal · doi:10.1042/bj20111671 · Cited by 109
Self-citationSCFCyclin F-dependent degradation of CDC6 suppresses DNA re-replication
Walter, D., Hoffmann, S., Komseli, E.-S., Rappsilber, J., Gorgoulis, V. G., & Sørensen, C. S. (2016) · Nature Communications · doi:10.1038/ncomms10530 · Cited by 109
Blocking an N-terminal acetylation–dependent protein interaction inhibits an E3 ligase
Scott, D. C., Hammill, J. T., Min, J., Rhee, D. Y., Connelly, M., Sviderskiy, V. O., Bhasin, D., Chen, Y., Ong, S. S., Chai, S. C., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2386 · Cited by 111
González‐Prieto, R., Cuijpers, S. A. G., Kumar, R., Hendriks, I. A., & Vertegaal, A. C. O. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1040965 · Cited by 108
Yu, L., Feng, L., Li, X., Li, S., Xu, Q., Pan, X., & Xiao, Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00134 · Cited by 106
Zhou, H., Lü, J., Liu, L., Bernard, D., Yang, C., Fernández‐Salas, E., Chinnaswamy, K., Layton, S. D., Stuckey, J. A., Yu, Q., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01243-7 · Cited by 106
Target protein localization and its impact on PROTAC-mediated degradation
Simpson, L. M., Glennie, L., Brewer, A., Zhao, J., Crooks, J., Shpiro, N., & Sapkota, G. P. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.08.004 · Cited by 112
Proteome-scale discovery of protein degradation and stabilization effectors
Poirson, J., Cho, H., Dhillon, A., Haider, S., Imrit, A. Z., Lam, M. H. Y., Alerasool, N., Lacoste, J., Mizan, L., Wong, C. J., et al. (2024) · Nature · doi:10.1038/s41586-024-07224-3 · Cited by 113
Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition
Vogl, A. M., Brockmann, M. M., Giusti, S. A., Maccarrone, G., Vercelli, C. A., Bauder, C. A., Richter, J. S., Roselli, F., Hafner, A., Dedic, N., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3912 · Cited by 112
Blank, J. L., Liu, X. J., Cosmopoulos, K., Bouck, D. C., Garcia, K., Bernard, H., Tayber, O., Hather, G., Liu, R., Narayanan, U., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1729 · Cited by 104
Self-citationA map of protein dynamics during cell-cycle progression and cell-cycle exit
Gookin, S. E., Min, M., Phadke, H., Chung, M., Moser, J. C., Miller, I., Carter, D., & Spencer, S. L. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2003268 · Cited by 113
Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction
Nguyen, H. C., Wang, W., & Xiong, Y. (2017) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-319-46503-6_12 · Cited by 105
Zhou, L., Jiang, Y., Liu, X., Li, L., Yang, X., Dong, C., Liu, X., Lin, Y., Yan, L., Yu, J., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0840-4 · Cited by 103
Self-citationCullin E3 Ligases and Their Rewiring by Viral Factors
Mahon, C., Krogan, N., Craik, C., & Pick, E. (2014) · Biomolecules · doi:10.3390/biom4040897 · Cited by 101
Pelham, C. J., Ketsawatsomkron, P., Groh, S., Grobe, J. L., de Lange, W. J., Ibeawuchi, S., Keen, H. L., Weatherford, E. T., Faraci, F. M., & Sigmund, C. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.011 · Cited by 104
Identification of NUB1 as a suppressor of mutant Huntingtin toxicity via enhanced protein clearance
Lu, B., Al‐Ramahi, I., Valencia, A., Wang, Q., Berenshteyn, F., Yang, H., Gallego‐Flores, T., Ichcho, S., Lacoste, A., Hild, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3367 · Cited by 109
Proteasome-associated deubiquitinases and cancer
Mofers, A., Pellegrini, P., Linder, S. T., & D’Arcy, P. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9697-6 · Cited by 106
The FBXW2–MSX2–SOX2 axis regulates stem cell property and drug resistance of cancer cells
Yin, Y., Xie, C., Li, H., Tan, M., Chen, G., Schiff, R., Xiong, X., & Sun, Y. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905973116 · Cited by 100
MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors
Knorr, K. L. B., Schneider, P., Meng, X. W., Dai, H., Smith, B. D., Hess, A. D., Karp, J. E., & Kaufmann, S. H. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.74 · Cited by 103
The ubiquitin–proteasome system and its potential application in hepatocellular carcinoma therapy
Chen, Y., Wu, H., & Shen, X. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.023 · Cited by 104
Chang, F.-M., Reyna, S. M., Granados, J. C., Wei, S., Innis‐Whitehouse, W., Maffi, S. K., Rodriguez, E., Slaga, T. J., & Short, J. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397703 · Cited by 109
Potu, H., Sgorbissa, A., & Brancolini, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1942 · Cited by 113
Kim, Y. S., Nagy, K. J., Keyser, S. G. L., & Schneekloth, J. S. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.04.001 · Cited by 98
Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin β1
Zhao, G., Gong, L., Su, D., Jin, Y., Guo, C., Yue, M., Yao, S., Qin, Z., Ye, Y., Tang, Y., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122779 · Cited by 96
Self-citationZhang, J., Wan, L., Dai, X., Sun, Y., & Wei, W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.02.001 · Cited by 115
Self-citationOncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation
Sahasrabuddhe, A. A., Chen, X., Feng, F. Y.-C., Velusamy, T., Lim, M. S., & Elenitoba‐Johnson, K. S. J. (2014) · Oncogene · doi:10.1038/onc.2013.571 · Cited by 105
Wei, D., & Sun, Y. (2010) · Genes & Cancer · doi:10.1177/1947601910382776 · Cited by 100
Systematic In Vivo RNAi Analysis Identifies IAPs as NEDD8-E3 Ligases
Broemer, M., Tenev, T., Rigbolt, K. T. G., Hempel, S., Blagoev, B., Silke, J., Ditzel, M., & Meier, P. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.11.011 · Cited by 102
The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors
Johnson, D. E. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-14-0005 · Cited by 94
Zhou, W., Xu, J., Tan, M., Li, H., Li, H., Wei, W., & Sun, Y. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.002 · Cited by 94
Edelmann, M. J., Nicholson, B., & Kessler, B. M. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002031 · Cited by 109
Post-translational modifications and their implications in cancer
Dutta, H., & Jain, N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1240115 · Cited by 106
Yang, D., Li, L., Liu, H., Wu, L., Luo, Z., Li, H., Zheng, S., Gao, H., Chu, Y., Sun, Y., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.113 · Cited by 99
Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
Guo, Z., Zheng, T., Chen, B., Luo, C., Ouyang, S., Gong, S., Li, J., Mao, L., Lian, F., Yang, Y., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.08.003 · Cited by 100
Mosadeghi, R., Reichermeier, K. M., Winkler, M., Schreiber, A., Reitsma, J. M., Zhang, Y., Stengel, F., Cao, J., Kim, M., Sweredoski, M. J., et al. (2016) · eLife · doi:10.7554/elife.12102 · Cited by 95
Zhou, Q., Li, H., Li, Y., Tan, M., Fan, S., Cao, C., Meng, F., Zhu, L., Zhao, L., Guan, M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.121582 · Cited by 102
Yang, D., Tan, M., Wang, G., & Sun, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034079 · Cited by 94
E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin
Huang, H., Ceccarelli, D. F. J., Orlicky, S. M., St‐Cyr, D. J., Ziemba, A. J., Garg, P., Plamondon, S., Auer, M., Sidhu, S. S., Marinier, A., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1412 · Cited by 100
Tan, M.-K. M., Lim, H.-J., & Harper, J. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05746-11 · Cited by 101
Chagraoui, J., Girard, S., Spinella, J.-F., Simon, L., Bonneil, E., Mayotte, N., MacRae, T., Coulombe-Huntington, J., Bertomeu, T., Moison, C., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2020.12.002 · Cited by 93
Uncovering Ubiquitin and Ubiquitin-like Signaling Networks
Vertegaal, A. C. O. (2011) · Chemical Reviews · doi:10.1021/cr200187e · Cited by 100
Duda, D. M., Olszewski, J. L., Tron, A. E., Hammel, M., Lambert, L. J., Waddell, M. B., Mittag, T., DeCaprio, J. A., & Schulman, B. A. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.044 · Cited by 97
Posttranslational Modification and Quality Control
Wang, X., Pattison, J. S., & Su, H. (2013) · Circulation Research · doi:10.1161/circresaha.112.268706 · Cited by 111
Advances in targeted degradation of endogenous proteins
Röth, S., Fulcher, L. J., & Sapkota, G. P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03112-6 · Cited by 92
CRL4ACRBN E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis
Liu, J., Ye, J., Zou, X., Xu, Z., Feng, Y., Zou, X., Chen, Z., Li, Y., & Cang, Y. (2014) · Nature Communications · doi:10.1038/ncomms4924 · Cited by 99
Neddylation mediates ventricular chamber maturation through repression of Hippo signaling
Zou, J., Ma, W., Li, J., Littlejohn, R., Zhou, H., Kim, I., Fulton, D. J., Chen, W., Weintraub, N. L., Zhou, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719309115 · Cited by 94
Genau, H. M., Huber, J., Baschieri, F., Akutsu, M., Dötsch, V., Farhan, H., Rogov, V. V., & Behrends, C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.040 · Cited by 111
Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis
Li, H., Tan, M., Jia, L., Wei, D., Zhao, Y., Chen, G., Xu, J., Zhao, L., Thomas, D. G., Beer, D. G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70297 · Cited by 93
An affinity-directed protein missile system for targeted proteolysis
Fulcher, L. J., Macartney, T., Bozatzi, P., Hornberger, A., Rojas-Fernandez, A., & Sapkota, G. P. (2016) · Open Biology · doi:10.1098/rsob.160255 · Cited by 91
Control of Cullin-Ring Ubiquitin Ligase Activity by Nedd8
Deshaies, R. J., Emberley, E. D., & Saha, A. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_4 · Cited by 97
Ryu, J., Li, S.-H., Park, H.-S., Park, J., Lee, B., & Chun, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188706 · Cited by 92
Deubiquitylating Enzymes and DNA Damage Response Pathways
Jacq, X., Kemp, M. I., Martin, N. M. B., & Jackson, S. P. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9635-3 · Cited by 99
SCF ubiquitin ligases in the maintenance of genome stability
Silverman, J. S., Skaar, J. R., & Pagano, M. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.10.004 · Cited by 98
Barghout, S. H., Patel, P. S., Wang, X., Xu, G. W., Kavanagh, S., Halgas, O., Zarabi, S. F., Gronda, M., Hurren, R., Jeyaraju, D. V., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0167-0 · Cited by 93
Self-citationWang, S., Zhao, L., Shi, X., Ding, L., Yang, L., Wang, Z.-Z., Shen, D., Tang, K., Li, X., Mamun, M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00113 · Cited by 95
Metadata
- Authors
- Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., Cullis, C. A., Doucette, A., Garnsey, J. J., Gaulin, J. L., Gershman, R. E., Lublinsky, A. R., McDonald, A., Mizutani, H., Narayanan, U., Olhava, E. J., Peluso, S., Rezaei, M., Sintchak, M. D., Talreja, T., Thomas, M. P., Traore, T., Vyskocil, S., Weatherhead, G. S., Yu, J., Zhang, J., Dick, L. R., Claiborne, C. F., Rolfe, M., Bolen, J. B., & Langston, S. P.
- Affiliations
- Takeda Oncology (United States) (US)
- Corresponding author
- Soucy, Teresa A.
- ORCID
- Venue
- Nature
- Published
- 2009-04
- Volume
- 458
- Issue
- 7239
- Pages
- 732-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2076194625
- Cited by
- 1,990
- References
- 46
- Citations by year
- 2026: 110 · 2025: 120 · 2024: 156 · 2023: 126 · 2022: 137 · 2021: 155 · 2020: 170 · 2019: 149 · 2018: 112 · 2017: 105 · 2016: 108 · 2015: 98 · 2014: 99 · 2013: 100 · 2012: 100
- FWCI
- 32.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- NEDD8-activating enzyme, MLN4924, cullin-RING ubiquitin ligases, ubiquitin-proteasome system, proteasome inhibitors, cancer cell death, tumor xenografts, small molecule inhibitors, antitumour activity
- MeSH terms
- NEDD8 Protein, Animals, Antineoplastic Agents, Cells, Cultured, Cyclopentanes, Enzyme Inhibitors, Female, Humans, Neoplasms, Pyrimidines, Transplantation, Heterologous, Ubiquitins, Ubiquitin-Activating Enzymes, Cullin Proteins, Cell Line, Tumor, Mice, Proteasome Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.